Aaron Rosenberg - Aug 9, 2024 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role: Chief Financial Officer
Signature: /s/ Qing Nian, as Attorney-in-Fact
Stock symbol: BGNE
Transactions as of: Aug 9, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/13/2024, 05:17 PM
Previous filing: Jul 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	Ordinary Shares	Award	$0	+119K		$0.00	119K	Aug 9, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BGNE	Share Option (Right to Buy)	Award	$0	+221K		$0.00	221K	Aug 9, 2024	Ordinary Shares	221K	$14.06	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F2	The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
F3	These securities vest over a four-year period as follows: 25% on the first anniversary of July 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.